Evidence map›Paper›PMID 38849524›Full record

ArticleNature neuroscience2024

Developmental origin of oligodendrocytes determines their function in the adult brain.

Sarah Foerster, Elisa M Floriddia, David van Bruggen, Petra Kukanja, Bastien Hervé, Shangli Cheng, Eosu Kim, Benjamin U Phillips, Christopher J Heath, Richa B Tripathi and 20 more

Abstract read
In one paragraph

Article in Nature neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cannabinoid CBCell communication and signaling : CCS · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Involvement of the EndothelialThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  18. Review
  19. The Many Lives of an Oligodendrocyte Precursor Cell.Annual review of neuroscience · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Sarah FoersterWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Elisa M FloriddiaLaboratory of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-2304-8114
David van BruggenLaboratory of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0001-6794-7731
Petra KukanjaLaboratory of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-1228-5923
Bastien HervéLaboratory of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-2610-8365
Shangli ChengMing Wai Lau Centre for Reparative Medicine, Stockholm and Hong Kong nodes, Karolinska Institutet, Stockholm, Sweden.
Eosu KimBehavioral and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0001-9472-9465
Benjamin U PhillipsBehavioral and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.
Christopher J HeathSchool of Life, Health and Chemical Sciences, The Open University, Milton Keynes, UK.
Richa B TripathiWolfson Institute for Biomedical Research, University College London, London, UK.
Cody CallDepartment of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0003-2254-4298
Theresa BartelsWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Katherine RidleyWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Björn NeumannWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Laura López-CruzBehavioral and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.
Abbe H CrawfordWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
Cian J LynchAltos Labs, Cambridge Institute of Science, Cambridge, UK.
Manuel SerranoAltos Labs, Cambridge Institute of Science, Cambridge, UK.ORCID http://orcid.org/0000-0001-7177-9312
Lisa SaksidaDepartment of Physiology and Pharmacology and Robarts Research Institute, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada.
David H RowitchWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-0079-0060
Wiebke MöbiusDepartment of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.ORCID http://orcid.org/0000-0002-2902-7165
Klaus-Armin NaveDepartment of Neurogenetics, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany.ORCID http://orcid.org/0000-0001-8724-9666
Matthew N RasbandDepartment of Neuroscience, Baylor College of Medicine, Houston, TX, USA.ORCID http://orcid.org/0000-0001-8184-2477
Dwight E BerglesDepartment of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-7133-7378
Nicoletta KessarisWolfson Institute for Biomedical Research, University College London, London, UK.ORCID http://orcid.org/0000-0003-1191-6009
William D RichardsonWolfson Institute for Biomedical Research, University College London, London, UK.ORCID http://orcid.org/0000-0001-7261-2485
Timothy J BusseyBehavioral and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-3180-3709
Chao ZhaoWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. czhao@altoslabs.com.ORCID http://orcid.org/0000-0003-1144-1621
Gonçalo Castelo-BrancoLaboratory of Molecular Neurobiology, Karolinska Institutet, Stockholm, Sweden. goncalo.castelo-branco@ki.se.ORCID http://orcid.org/0000-0003-2247-9393
Robin J M FranklinWellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. rfranklin@altoslabs.com.ORCID http://orcid.org/0000-0001-6522-2104

Funding

Training Program in NeuroscienceT32NS091018 · NINDS · JOHNS HOPKINS UNIVERSITY · PI JAMES J KNIERIM, Daniel Hans O'Connor · 2015 to 2026
$4.1M
Aging dependent transformation of oligodendrocyte precursor cellsR01AG072305 · NIA · JOHNS HOPKINS UNIVERSITY · PI BERGLES, DWIGHT E, GOFF, LOYAL ANDREW · 2021 to 2025
$2.0M
DH | National Institute for Health Research (NIHR) AG072305Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (Dr. Miriam & Sheldon G. Adelson Medical Research Foundation) n/aEC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 681893Hjärnfonden (Swedish Brain Foundation) F02017-0075Medical Research Council MC_PC_17230Multiple Sclerosis Society (MS Society) n/aNational Centre for the Replacement Refinement and Reduction of Animals in Research (NC3Rs) NC-N001451-1NIA NIH HHS R01 AG072305NINDS NIH HHS T32 NS091018RCUK | Medical Research Council (MRC) G0800575RCUK | Medical Research Council (MRC) n/aSvenska Läkaresällskapet (Swedish Society of Medicine) JUB 2019Vetenskapsrådet (Swedish Research Council) 2015-03558; 2019-01360Wellcome TrustWellcome Trust (Wellcome) 011269/Z/12/ZWellcome Trust (Wellcome) 100269-Z/12/Z; 108726-Z/15/ZWellcome Trust (Wellcome) n/a
6 · The paper itself

Abstract

In the mouse embryonic forebrain, developmentally distinct oligodendrocyte progenitor cell populations and their progeny, oligodendrocytes, emerge from three distinct regions in a spatiotemporal gradient from ventral to dorsal. However, the functional importance of this oligodendrocyte developmental heterogeneity is unknown. Using a genetic strategy to ablate dorsally derived oligodendrocyte lineage cells (OLCs), we show here that the areas in which dorsally derived OLCs normally reside in the adult central nervous system become populated and myelinated by OLCs of ventral origin. These ectopic oligodendrocytes (eOLs) have a distinctive gene expression profile as well as subtle myelination abnormalities. The failure of eOLs to fully assume the role of the original dorsally derived cells results in locomotor and cognitive deficits in the adult animal. This study reveals the importance of developmental heterogeneity within the oligodendrocyte lineage and its importance for homeostatic brain function.

Indexed as

BrainCell LineageOligodendrogliaAnimalsCell DifferentiationMiceMice, TransgenicMyelin Sheath

Identifiers

PMID38849524
PMCPMC11303253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.